Table 2 Expression of immunomarkers in endometrial carcinoma and their prognostic significance

From: Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data

Marker

% of cases positive

Prognostic value (P-value)a

p53

19.7% (35/178)

<0.0001

ER

84.3% (150/178)

0.0002

bcl-2

27.4% (46/168)

0.035

HER2

4.5% (8/178)

0.0001

p21

30% (52/174)

0.06

p27

38.2% (65/170)

0.0125

E2F-1

26% (46/176)

0.0245

PTEN

40% (67/168)

0.0042

p63

16% (27/170)

0.24

Gfi-1

36.6% (60/164)

0.4

B72.3

39% (66/169)

0.89

CK5/6

60% (102/170)

0.83

  1. aBy univariate analysis.
Back to article page